Skip to main content
SpringerLink
Log in

New treatment options for hypertension during acute ischemic or hemorrhagic stroke

  • Published:
Current Treatment Options in Cardiovascular Medicine Aims and scope Submit manuscript

Opinion statement

Widespread reluctance to treat hypertension during acute stroke is based on historical accounts of unfavorable outcomes of treatment that were badly done: therapies that cannot be controlled, such as sublingual nifedipine, oral or intramuscular antihypertensive drugs may drop blood pressure precipitously, leading to worsening of ischemia. Case fatality in stroke obeys a U-shaped relationship: blood pressures that are either too low or too high are associated with worse outcomes both in ischemic stroke and in intracerebral hemorrhage. Very high blood pressures should be lowered in acute stroke, and there are some circumstances in which high blood pressure must be treated despite the presence of stroke. To avoid worsening of ischemia by reduction in cerebral blood flow, it is necessary to treat high blood pressure in acute stroke with drugs that can be controlled; this usually means giving drugs by intravenous infusion; however, there is recent evidence that transdermal administration of nitrates, which can be removed if pressure is too low, is a convenient alternative that does not reduce cerebral blood flow in acute stroke.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Leonardi-Bee J, Bath PM, Phillips SJ, Sandercock PA: Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 2002, 33:1315–1320.

    Article  PubMed  Google Scholar 

  2. Okumura K, Ohya Y, Maehara A, et al.: Effects of blood pressure levels on case fatality after acute stroke. J Hypertens 2005, 23:1217–223.

    Article  PubMed  CAS  Google Scholar 

  3. Dandapani BK, Suzuki S, Kelley RE, et al.: Relation between blood pressure and outcome in intracerebral hemorrhage. Stroke 1995, 26:21–24.

    PubMed  CAS  Google Scholar 

  4. Adams H, Adams R, Del ZG, Goldstein LB: Guidelines for the early management of patients with ischemic stroke: 2005 guidelines up date a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke 2005, 36:916–923.

    Article  PubMed  Google Scholar 

  5. Yatsu FM, Zivin J: Hypertension in acute ischemic strokes. Not to treat. Arch Neurol 1985, 42:999–1000.

    PubMed  CAS  Google Scholar 

  6. Spence JD, Del Maestro RF: Hypertension in acute ischemic strokes. Treat. Arch Neurol 1985, 42:1000–1002.

    PubMed  CAS  Google Scholar 

  7. Bath P, Chalmers J, Powers W, et al.: International Society of Hypertension (ISH): statement on the management of blood pressure in acute stroke. J Hypertens 2003, 21:665–672.

    Article  PubMed  Google Scholar 

  8. Chalmers J: Blood pressure and stroke: a continuing debate. J Hypertens 2006, 24:1249–1251.

    Article  PubMed  CAS  Google Scholar 

  9. Willmot M, Ghadami A, Whysall B, et al.: Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. Hypertension 2006, 47:1209–1215.

    Article  PubMed  CAS  Google Scholar 

  10. Bath PM: Major ongoing stroke trials. Efficacy of Nitric Oxide in Stroke (ENOS) trial [abstract]. Stroke 2001, 32:2450–2451.

    Google Scholar 

  11. Doba N, Reis DJ: Acute fulminating neurogenic hypertension produced by brainstem lesions in the rat. Circ Res 1973, 32:584–593.

    PubMed  CAS  Google Scholar 

  12. Nathan MA, Reis DJ: Fulminating arterial hypertension with pulmonary edema from release of adrenomedullary catecholamines after lesions of the anterior hypothalamus in the rat. Circ Res 1975, 37:226–235.

    PubMed  CAS  Google Scholar 

  13. Mazey RM, Kotchen TA, Ernst CB: A syndrome resembling pheochromocytom a following a stroke. Report of a case. JAMA 1974, 230:575–577.

    Article  PubMed  CAS  Google Scholar 

  14. Willmot M, Leonardi-Bee J, Bath PM: High blood pressure in acute stroke and subsequent outcome: a systematic review. Hypertension 2004, 43:18–24.

    Article  PubMed  CAS  Google Scholar 

  15. Sprigg N, Gray LJ, Bath PM, et al.: Relationship between outcome and baseline blood pressure and other haemodynamic measures in acute ischaemic stroke: data from the TAIST trial. J Hypertens 2006, 24:1413–1417.

    Article  PubMed  CAS  Google Scholar 

  16. Halsey JH Jr, O’Brien MD: Role of hypertension in pathogenesis of cerebral infarction edema. Adv Neurol 1980, 28:317–321.

    PubMed  Google Scholar 

  17. Hayakawa T, Waltz AG, Jacobson RL: Hypertension and acute focal cerebral ischemia. Infarction and edem a after occlusion of a middle cerebral artery in cats. Stroke 1979, 10:263–267.

    PubMed  CAS  Google Scholar 

  18. Karki A, Westergren I, Widner H, et al.: Tirilazad reduces brain edem a after middle cerebral artery ligation in hypertensive rats. Acta Neurochir Suppl (Wien) 1994, 60:310–313.

    CAS  Google Scholar 

  19. Paulson OB, Lassen NA, Skinhoj E: Regional cerebral blood flow in apoplexy without arterial occlusion. Neurology 1970, 20:125–138.

    PubMed  CAS  Google Scholar 

  20. Strandgaard S: Autoregulation of cerebral blood flow in hypertensive patients. The modifying influence of prolonged antihypertensive treatment on the tolerance to acute, drug-induced hypotension. Circulation 1976, 53:720–727.

    PubMed  CAS  Google Scholar 

  21. van HJ, Burggraaf K, Danhof M, et al.: Negligible sublingual absorption of nifedipine. Lancet 1987, 2:1363–1365.

    Google Scholar 

  22. Schrader J, Luders S, Kulschewski A, et al.: The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors. Stroke 2003, 34:1699–1703.

    Article  PubMed  Google Scholar 

  23. Hackam DG, Thain LM, Abassakoor A, et al.: Trapped renal arteries: functional renal artery stenosis due to occlusion of the aorta in the arch and below the kidneys. Can J Cardiol 2001, 17:587–592.

    PubMed  CAS  Google Scholar 

  24. Spence JD: Management of resistant hypertension in patients with carotid stenosis: high prevalence of renovascular hypertension. Cerebrovasc Dis 2000, 10:249–254.

    Article  PubMed  CAS  Google Scholar 

  25. Spence JD: Individualized therapy for hypertension. Hypertension 2006, 47:e11.

    Article  PubMed  CAS  Google Scholar 

  26. Spence JD: Physiologic tailoring of therapy for resistant hypertension: 20 years’ experience with stimulated renin profiling. Am J Hypertens 1999, 12(11 Pt 1):1077–1083.

    PubMed  CAS  Google Scholar 

  27. Biglieri EG, Kater CE, Arteaga EE: Primary aldosteronism is comprised of primary adrenal hyperplasia and adenoma. J Hypertens Suppl 1984, 2:S259–S261.

    PubMed  CAS  Google Scholar 

  28. Baker EH, Duggal A, Dong Y, et al.: Amiloride, a specific drug for hypertension in black people with T594M variant? Hypertension 2002, 40:13–17.

    Article  PubMed  CAS  Google Scholar 

  29. Wallach L, Nyarai I, Dawson KG: Stimulated renin: a screening test for hypertension. Ann Intern Med 1975, 82:27–34.

    PubMed  CAS  Google Scholar 

  30. Butterworth RJ, Cluckie A, Jackson SH, et al.: Pathophysiological assessment of nitric oxide (given as so dium nitroprusside) in acute ischaemic stroke. Cerebrovasc Dis 1998, 8:158–165.

    Article  PubMed  CAS  Google Scholar 

  31. Rindone JP, Sloane EP: Cyanide toxicity from sodium nitroprusside: risks and management. Ann Pharmacother 1992, 26:515–519.

    PubMed  CAS  Google Scholar 

  32. Alaniz C, Watts B: Monitoring cyanide toxicity in patients receiving nitroprusside therapy. Ann Pharmacother 2005, 39:388–389.

    Article  PubMed  Google Scholar 

  33. Gogbashian A: Nitroprusside in critically ill patients with aortic stenosis. N Engl J Med 2003, 349:811–813.

    Article  PubMed  Google Scholar 

  34. Khot UN, Novaro GM, Popovic ZB, et al.: Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis. N Engl J Med 2003, 348:1756–1763.

    Article  PubMed  CAS  Google Scholar 

  35. Sinaiko AR: Hypertension in children. N Engl J Med 1996, 335:1968–1973.

    Article  PubMed  CAS  Google Scholar 

  36. Spence JD: Treating hypertension in acute stroke: a better arrow for the quiver. Hypertension 2006, 47:1051.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Stroke Prevention & Atherosclerosis Research Centre, Robarts Research Institute, 1400 Western Road, London, ON, N6G 2V2, Canada

    J. David Spence MD

Authors
  1. J. David Spence MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. David Spence MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Spence, J.D. New treatment options for hypertension during acute ischemic or hemorrhagic stroke. Curr Treat Options Cardio Med 9, 242–246 (2007). https://doi.org/10.1007/s11936-007-0019-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11936-007-0019-0

Keywords

Search

Navigation